Clorox is considering adjustments to its sourcing strategies to counterbalance a $100 million impact from tariffs.

Clorox is exploring sourcing and product formulation adjustments to counter a $100 million tariff impact starting in July, according to CFO Luc Bellet. The company's limited exposure to tariffs comes from manufacturing close to its markets, allowing it to manage the financial repercussions over time. Clorox differs from competitors like Procter & Gamble, which is delaying supply chain changes, and is actively storing surplus inventory to mitigate potential price increases. Economic uncertainty from tariffs is also influencing consumer purchasing behavior, prompting more cautious use of products.